TGTX · Company research
TG Therapeutics, Inc. (TGTX): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 52.19 | $8,915,353,029.33 | 8818344029.33 | 1123.8000000000000000 | — | — | 37.0955251183972372 | 220.3879323988332139 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.